Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity.
- Published In:
- International journal of molecular sciences, 25(3) (2024)
- Database ID:
- RPEP-08165
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08165APA
Eržen, Stjepan; Tonin, Gašper; Jurišić Eržen, Dubravka; Klen, Jasna. (2024). Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity.. International journal of molecular sciences, 25(3). https://doi.org/10.3390/ijms25031517
MLA
Eržen, Stjepan, et al. "Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity.." International journal of molecular sciences, 2024. https://doi.org/10.3390/ijms25031517
RethinkPeptides
RethinkPeptides Research Database. "Amylin, Another Important Neuroendocrine Hormone for the Tre..." RPEP-08165. Retrieved from https://rethinkpeptides.com/research/erzen-2024-amylin-another-important-neuroendocrine
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.